The pathway to inflammation in asthma: the role of the DP2 receptor

O. Palomares (Madrid, Spain)

Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Session: The journey towards personalized medicine in asthma: where are we now?
Session type: Evening Symposium
Number: 3466
Disease area: Airway diseases

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Palomares (Madrid, Spain). The pathway to inflammation in asthma: the role of the DP2 receptor. International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007



LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015

Toll-like receptor stimulation induces airway hyperresponsiveness to bradykinin, an effect mediated by JNK and NF-κB signaling pathways
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005

TGFβ overproduction in asthma reduces the epithelial repair by down-regulating the leptin/leptin receptor pathway
Source: Eur Respir J 2007; 30: Suppl. 51, 59s
Year: 2007

The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


The serotoninergic receptor subtype 5-HTR1B contributes to the pathogenesis of allergic airway inflammation
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012

A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002

A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008


Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


The effects of formyl peptide receptor agonist on the asthma pathogenesis
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010

NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Source: Eur Respir J 2016; 47: 254-263
Year: 2016



Activation of eosinophils via toll-like receptor (TLR)3, TLR7 and TLR9: link between viral infection and asthma?
Source: Annual Congress 2007 - Novel aspects in airway inflammation in human asthma and rhinitis
Year: 2007



Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Source: Eur Respir J 2008; 32: 1213-1223
Year: 2008



Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010